111 related articles for article (PubMed ID: 2108487)
1. Swainsonine, an inhibitor of glycoprotein processing, enhances cytotoxicity of large granular lymphocytes.
Yagita M; Saksela E
Scand J Immunol; 1990 Mar; 31(3):275-82. PubMed ID: 2108487
[TBL] [Abstract][Full Text] [Related]
2. Swainsonine, an inhibitor of glycoprotein processing, enhances mitogen induced interleukin 2 production and receptor expression in human lymphocytes.
Bowlin TL; Sunkara PS
Biochem Biophys Res Commun; 1988 Mar; 151(2):859-64. PubMed ID: 3126744
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of human lymphokine-activated killer cell activity by swainsonine, an inhibitor of glycoprotein processing.
Bowlin TL; McKown BJ; Kang MS; Sunkara PS
Cancer Res; 1989 Aug; 49(15):4109-13. PubMed ID: 2501020
[TBL] [Abstract][Full Text] [Related]
4. The presence of concanavalin-A(Con-A)-like molecules on natural-killer (NK)-sensitive target cells: their possible role in swainsonine-augmented human NK cytotoxicity.
Yagita M; Noda I; Maehara M; Fujieda S; Inoue Y; Hoshino T; Saksela E
Int J Cancer; 1992 Oct; 52(4):664-72. PubMed ID: 1399150
[TBL] [Abstract][Full Text] [Related]
5. Swainsonine, an inhibitor of mannosidase II during glycoprotein processing, enhances concanavalin A-induced T cell proliferation and interleukin 2 receptor expression exclusively via the T cell receptor complex.
Bowlin TL; Schroeder KK; Fanger BO
Cell Immunol; 1991 Oct; 137(1):111-7. PubMed ID: 1832085
[TBL] [Abstract][Full Text] [Related]
6. Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity.
Galustian C; Foulds S; Dye JF; Guillou PJ
Immunopharmacology; 1994; 27(2):165-72. PubMed ID: 7516929
[TBL] [Abstract][Full Text] [Related]
7. Effect of swainsonine on interleukin-2 alpha chain receptor expression and proliferation of human lymphocytes.
Myc A; DeAngelis P; Lassota P; Melamed MR; Darzynkiewicz Z
Clin Exp Immunol; 1991 Jun; 84(3):406-10. PubMed ID: 1904326
[TBL] [Abstract][Full Text] [Related]
8. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
[TBL] [Abstract][Full Text] [Related]
9. Regulation of large granular lymphocytes and human T cell growth and function by recombinant interleukin 2. II. Acquisition of potent cytotoxic capabilities.
Yamada S; Ortaldo JR
J Leukoc Biol; 1987 Sep; 42(3):263-72. PubMed ID: 3114401
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of glycoprotein processing alter T-cell proliferative responses to antigen and to interleukin 2.
Wall KA; Pierce JD; Elbein AD
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5644-8. PubMed ID: 3135550
[TBL] [Abstract][Full Text] [Related]
11. Swainsonine augments the cytotoxicity of human lymphokine-activated killer cells against autologous thyroid cancer cells.
Fujieda S; Noda I; Saito H; Hoshino T; Yagita M
Arch Otolaryngol Head Neck Surg; 1994 Apr; 120(4):389-94. PubMed ID: 8166967
[TBL] [Abstract][Full Text] [Related]
12. Role of target cell glycoproteins in sensitivity to natural killer cell lysis.
Ahrens PB
J Biol Chem; 1993 Jan; 268(1):385-91. PubMed ID: 8093244
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate synthesis inhibitors decrease interleukin 1-stimulated lymphocyte binding to endothelial cells.
Renkonen R; Ustinov J
Eur J Immunol; 1991 Mar; 21(3):777-81. PubMed ID: 1672647
[TBL] [Abstract][Full Text] [Related]
14. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
15. Decreased interleukin-2 beta-chain receptor expression by interleukin-4 on LGL: influence on the IL-2 induced cytotoxicity and proliferation.
Lindqvist C; Ostman AL; Okerblom C; Akerman K
Cancer Lett; 1992 May; 64(1):43-9. PubMed ID: 1596876
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity.
Yamada S; Ruscetti FW; Overton WR; Herberman RB; Birchenall-Sparks MC; Ortaldo JR
J Leukoc Biol; 1987 Jun; 41(6):505-17. PubMed ID: 3110337
[TBL] [Abstract][Full Text] [Related]
17. IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-gamma production, and cytotoxicity of human peripheral blood lymphocytes subsets.
Smyth MJ; Norihisa Y; Gerard JR; Young HA; Ortaldo JR
Cell Immunol; 1991 Dec; 138(2):390-403. PubMed ID: 1834347
[TBL] [Abstract][Full Text] [Related]
18. Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors.
Blay JY; Bertoglio J; Fradelizi D; Chouaib S
Int J Cancer; 1989 Oct; 44(4):598-604. PubMed ID: 2793231
[TBL] [Abstract][Full Text] [Related]
19. Effect of swainsonine on stimulation and cell cycle progression of human lymphocytes.
Myc A; Kunicka JE; Melamed MR; Darzynkiewicz Z
Cancer Res; 1989 Jun; 49(11):2879-83. PubMed ID: 2497968
[TBL] [Abstract][Full Text] [Related]
20. A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A.
Morioka N; Sze LL; Morton DL; Irie RF
Cancer Immunol Immunother; 1993 Oct; 37(5):316-22. PubMed ID: 8402735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
